Chatarina Lofqvist
Overview
Explore the profile of Chatarina Lofqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sjobom U, Isaksson J, Wickelgren R, Vallin L, Nilsson A, Hellstrom A, et al.
Acta Paediatr
. 2025 Feb;
PMID: 39976157
Aim: The Extremely Preterm Infant Target Optimise and Prevent (EPITOP) study aimed to develop an ethical and practical approach to biobanking salvaged residual blood samples from extremely preterm infants (< ...
2.
Hansson M, Pivodic A, Lofqvist C, Savman K, Hallberg B, Ley D, et al.
Acta Paediatr
. 2025 Jan;
PMID: 39791460
Aim: To analyse the challenges faced by parents of extremely preterm infants born before 24 weeks of gestation and the potential buffering effect of perceived resources on the family's health...
3.
Nilsson A, Sjobom U, Landin A, Andersson M, Ryberg H, Pivodic A, et al.
J Endocr Soc
. 2024 Nov;
8(12):bvae179.
PMID: 39512921
Context: Neurodevelopmental impairments are common among survivors of extremely preterm birth, particularly in males. Hyperactivation of the hypothalamic-pituitary-gonadal (HPG) axis has been suggested as an underlying cause, but this has...
4.
Sjobom U, Ohrfelt A, Pivodic A, Nilsson A, Blennow K, Zetterberg H, et al.
Pediatr Res
. 2024 Sep;
PMID: 39317698
Background: Neurofilament light chain (NfL) is known for indicating adult brain injury, but the role of NfL in extremely preterm infants is less studied. This study examines the relationship between...
5.
Sjobom U, Hellqvist T, Humayun J, Nilsson A, Gyllensten H, Hellstrom A, et al.
Ophthalmol Sci
. 2024 Aug;
4(6):100548.
PMID: 39184225
Topic: Retinopathy of prematurity (ROP) is a severe retinal vascular disorder affecting preterm infants, potentially leading to retinal detachment and blindness. This review aims to elucidate the relationship between systemic...
6.
Pivodic A, Hansson M, Lofqvist C, Savman K, Elfvin A, Jacobson L, et al.
Acta Paediatr
. 2024 Jul;
113(11):2414-2422.
PMID: 38984707
Aim: To assess experience of care, well-being of parents and children's development in a cohort of extremely premature infants born <24 weeks of gestation in Sweden from 2007 to 2018....
7.
Pivodic A, Holmstrom G, Smith L, Hard A, Lofqvist C, Al-Hawasi A, et al.
JAMA Ophthalmol
. 2023 Jun;
141(8):716-724.
PMID: 37382945
Importance: The prognostic impact of parenteral nutrition duration (PND) on retinopathy of prematurity (ROP) is not well studied. Safe prediction models can help optimize ROP screening by effectively discriminating high-risk...
8.
Sjobom U, Andersson M, Pivodic A, Lund A, Vanpee M, Hansen-Pupp I, et al.
Clin Nutr
. 2023 Apr;
42(6):962-971.
PMID: 37120902
Background & Aim: Preterm infants risk deficits of long-chain polyunsaturated fatty acids (LCPUFAs) that may contribute to morbidities and hamper neurodevelopment. We aimed to determine longitudinal serum fatty acid profiles...
9.
Gyllensten H, Humayun J, Sjobom U, Hellstrom A, Lofqvist C
BMJ Open
. 2022 Nov;
12(11):e057864.
PMID: 36424118
Objectives: To review and analyse evidence regarding costs for retinopathy of prematurity (ROP) screening, lifetime costs and resource use among infants born preterm who develop ROP, and how these costs...
10.
Sjobom U, Nilsson A, Gyllensten H, Hellstrom A, Lofqvist C
PLoS One
. 2022 Jul;
17(7):e0270232.
PMID: 35793362
Background: Intraocular treatment with antibodies targeting vascular endothelial growth factor (anti-VEGF) inhibits pathological vessel growth in adults and preterm infants. Recently, concerns regarding the impact of anti-VEGF treatment on systemic...